Incannex Healthcare (IXHL) Total Non-Current Liabilities (2020 - 2026)
Incannex Healthcare's (IXHL) quarterly Total Non-Current Liabilities came in at $2.0 million in Q1 2026, down 73.65% year-on-year from $7.5 million in Q1 2025, and down 73.65% quarter-over-quarter from $7.5 million in Q1 2025.
Incannex Healthcare (IXHL) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends
Incannex Healthcare has disclosed Total Non-Current Liabilities across 5 years of filings, most recently posting $2.0 million for Q1 2026.
- Total Non-Current Liabilities for Q1 2026 came in at $2.0 million, down 73.65% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.0 million (down 73.65% YoY), and the FY2023 annual result was $616087.0, changed N/A from the prior year.
- Total Non-Current Liabilities came in at $2.0 million for Q1 2026 at Incannex Healthcare, down from $7.5 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $8.9 million in Q4 2024 to a low of $616087.0 in Q2 2023.
- The 4-year median for Total Non-Current Liabilities is $3.5 million (2023), against an average of $4.5 million.
- Across the five-year window, Total Non-Current Liabilities soared 153.94% in 2024 and plunged 73.65% in 2026, its largest moves.
- Incannex Healthcare's Total Non-Current Liabilities stood at $3.5 million in 2023, then jumped by 153.94% to $8.9 million in 2024, then decreased by 15.62% to $7.5 million in 2025, then slumped by 73.65% to $2.0 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $2.0 million (Q1 2026), $7.5 million (Q1 2025), and $8.9 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 18.28 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 11.64 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 44.12 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.24 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.26 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 2.44 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.81 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.13 Bn |
| 10 | Incannex Healthcare | 45.81 Mn | 45.81 Mn | - | 1.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.97 Mn |
| Mar 31, 2025 | 7.47 Mn |
| Dec 31, 2024 | 8.86 Mn |
| Dec 31, 2023 | 3.49 Mn |
| Jun 30, 2023 | 616,087.00 |
| Jun 30, 2020 | 955,006.00 |